Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 5:48 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,432 | $132.94 | $190,371.00 | (10%) 14.56K to 13.13K | |
| 02-Feb-24 7:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 126 | $141.94 | $17,884.40 | (1%) 11.97K to 11.84K | |
| 01-Dec-23 5:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 29-Nov-23 | Private Sale (Planned) | 2,331 | $113.57 | $264,733.00 | (17%) 14.06K to 11.73K | |
| 23-Aug-23 8:10 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 3,198 | $107.37 | $343,368.00 | (25%) 12.84K to 9.64K | |
| 08-Feb-23 7:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Private Sale (Planned) | 4,508 | $102.30 | $461,166.00 | (41%) 11.03K to 6.53K | |
| 02-Feb-23 5:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 126 | $108.48 | $13,668.50 | (5%) 2.6K to 2.48K | |
| 01-Dec-22 6:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 29-Nov-22 | Private Sale (Planned) | 2,331 | $121.90 | $284,160.00 | (50%) 4.7K to 2.37K |